Join us on Thursday, 23 November 2023 from 7:00 pm to 8:00 pm (AEDT) as we discuss the following in relation to the role of SGLT2 inhibitors in type 2 diabetes:

• The benefits of SGLT2i on glycaemia, CVD and CLD
• The benefits of early glycaemic management of type 2 diabetes
• Addressing the barriers for SGLT2i use in type 2 diabetes
• The ideal situation for SGLT2i initiation

Speakers

Click here to view the event flyer.
Click here to register for the webinar.

This webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request.

For any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au